K Number
K082657
Device Name
RTX RESPIRATOR
Manufacturer
Date Cleared
2008-10-08

(26 days)

Product Code
Regulation Number
868.5935
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
1) Ventilation - The RTX Respirator is indicated for external ventilation of the lungs resulting in gas exchange. 2) Secretion Clearance - Also for use in assisting patients with secretion clearance management as indicated by standard medical convention. The RTX Respirator is for use in adult and pediatric patient populations. The RTX is not for use in out-of-hospital transport. For prescription use only.
Device Description
The RTX Respirator is an external high and low frequency respirator, which controls both phases of respiration. It consists of a lightweight flexible cuirass, tubing with a keypad and display screen. The Cuirass is available in eleven (11) sizes for various patient populations and sizes. The Cuirass contains a disposable seal and is attached to the patient via Velcro and nylon straps. The RTX Respirator ventilates by decreasing and then increasing the pressure within the cuirass. The negative pressure creates expansion of the chest bringing about inspiration. The positive phase creates positive pressure on the chest and therefore creates expiration.
More Information

Not Found

No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and the device description focuses on mechanical principles of ventilation.

Yes
The device is indicated for "external ventilation of the lungs" and "assisting patients with secretion clearance management," which are therapeutic actions.

No

The device is described as a respirator for ventilation and secretion clearance, which are therapeutic functions, not diagnostic ones. Its purpose is to assist gas exchange and manage secretions, not to identify or assess a medical condition.

No

The device description explicitly mentions hardware components such as a cuirass, tubing, keypad, and display screen, indicating it is not solely software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens, including blood, tissue, and urine, derived from the human body, to provide information for diagnostic, monitoring or compatibility purposes.
  • Device Description and Intended Use: The RTX Respirator is described as an external respirator that provides ventilation and assists with secretion clearance by applying pressure changes to the chest. Its intended use is for external ventilation of the lungs and secretion clearance management.
  • Lack of Specimen Examination: The device does not involve the examination of any specimens (blood, tissue, urine, etc.) from the human body. It directly interacts with the patient's external chest and lungs.

Therefore, the RTX Respirator falls under the category of a therapeutic device rather than an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

    1. Ventilation -
      The RTX Respirator is indicated for external ventilation of the lungs resulting in gas exchange.
    1. Secretion Clearance -
      Also for use in assisting patients with secretion clearance management as indicated by standard medical convention

The RTX Respirator is for use in adult and pediatric patient populations. The RTX is not for use in out-of-hospital transport. For prescription use only.

Product codes (comma separated list FDA assigned to the subject device)

BYT

Device Description

The RTX Respirator is an external high and low frequency respirator, which controls The ICTA respirator is an oneoncele. It consists of a lightweight flexible cuirass, tubing both phases or its with a keypad and display screen. The Cuirass is available is eleven (II) and a power various patient populations and sizes. The Cuirass contains a disposable seal and is attached to the patient via Velcro and nylon straps.

The RTX Respirator ventilates by decreasing and then increasing the pressure within the The NTA Respirator vennator vontrolled, triggered or synchronized inspiration and expiration. The negative pressure creates expansion of the chest bringing about inspiration. The nogative phase creates positive pressure on the chest and therefore creates expiration.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

lungs

Indicated Patient Age Range

adult and pediatric patient populations

Intended User / Care Setting

For prescription use only. The RTX is not for use in out-of-hospital transport.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Clinical Evaluation 6.2
A comparative clinical study was performed and the RTX Respirator was shown A comparative onlined brady mas to the predicate Hayek Oscillator (K924341) to eximbly a simmal patter results. Also, a review of recent publications on the RTX Respirator showed it to be a safe and effective device.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K924341, K841529, K884098

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 868.5935 External negative pressure ventilator.

(a)
Identification. An external negative pressure ventilator (e.g., iron lung, cuirass) is a device chamber that is intended to support a patient's ventilation by alternately applying and releasing external negative pressure over the diaphragm and upper trunk of the patient.(b)
Classification. Class II (performance standards).

0

Ko 8 a657

510(k) Summary

(per 21 CFR 807.92(c))

1. Applicant

Medivent Limited. Maryland House 10 The Downage London NW4 1AA UK

Contact Person: Shahar Hayek, Managing Director Tel: 44 870 300 5527 Fax: 44 870 300 5528 Email; shahar@mediventintl.com Date Prepared: August 25, 2008

2. Device Name

Trade Name: RTX Respirator Common/Usual Name: Non-Invasive Cuirass Respirator Classification Name: External negative pressure ventilator Regulation Number: 868.5935 Product Codes: BYT Classification: II Classification Panel: Anesthesiology

3. Predicate Devices

The RTX Respirator is substantially equivalent to the following devices:

510(k) NumberDeviceManufacturer
K924341Hayek OscillatorRespironics
K841529Servo Ventilator 900CSiemens
K884098Thairapy TM Bronchial Drainage
System, Model 101 now known as The
Vest Airway Clearance SystemOriginally manufactured by
American Biosystems but
now manufactured by Hill-
Rom

1

4. Intended Use

    1. Ventilation -
      The RTX Respirator is indicated for external ventilation of the lungs resulting in gas exchange.
    1. Secretion Clearance -
      Also for use in assisting patients with secretion clearance management as indicated by standard medical convention

The RTX Respirator is for use in adult and pediatric patient populations. The RTX is not for use in out-of-hospital transport. For prescription use only.

5. Description of the Device

The RTX Respirator is an external high and low frequency respirator, which controls The ICTA respirator is an oneoncele. It consists of a lightweight flexible cuirass, tubing both phases or its with a keypad and display screen. The Cuirass is available is eleven (II) and a power various patient populations and sizes. The Cuirass contains a disposable seal and is attached to the patient via Velcro and nylon straps.

The RTX Respirator ventilates by decreasing and then increasing the pressure within the The NTA Respirator vennator vontrolled, triggered or synchronized inspiration and expiration. The negative pressure creates expansion of the chest bringing about inspiration. The nogative phase creates positive pressure on the chest and therefore creates expiration.

6. Summary of the Technical Characteristics

  • Electrical Testing 6.1
    The RTX Respirator was tested and found to be compliant to IEC 60601-1-2, The RTA Respirator was tested anno-3-2/3, IEC 61000-4-2/3/4/5/6/8/11, and IEC 60601-1.

  • Clinical Evaluation 6.2
    A comparative clinical study was performed and the RTX Respirator was shown A comparative onlined brady mas to the predicate Hayek Oscillator (K924341) to eximbly a simmal patter results. Also, a review of recent publications on the RTX Respirator showed it to be a safe and effective device.

2

7. Safety & Effectiveness

There are no known substantial differences between the RTX Respirator defined in this 510(k) submission and the predicate devices. They have the same or similar intended indications for use and any differences in technological characteristics do not raise issues of safety and effectiveness.

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES. USA" arranged in a circular fashion around the eagle. The logo is black and white and appears to be a simple, vectorized design. The eagle is facing to the right.

Public Health Service

OCT 0 8 2008

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Medivent Limited C/O Mr. Jay Y. Kogoma Responsible Third Party Official Intertek Testing Services NA, Incorporated 2307 East Aurora Road, Unit B7 Twinsburg, Ohio 44087

Re: K082657

Trade/Device Name: RTX Respirator Regulation Number: 21 CFR 868.5935 Regulation Name: External Negative Pressure Ventilator Regulatory Class: II Product Code: BYT Dated: September 29, 2008 Received: September 30, 2008

Dear Mr. Kogoma:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

4

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

Th. Manuelo Sendong foch

Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

Indications for Use

510(k) Number (if known):

Device Name: RTX Respirator

Indications for Use:

    1. Ventilation -
      The RTX Respirator is indicated for external ventilation of the lungs resulting in gas exchange.
    1. Secretion Clearance -
      Also for use in assisting patients with secretion clearance management as indicated by standard medical convention

The RTX Respirator is for use in adult and pediatric patient populations. The RTX is not for use in out-of-hospital transport. For prescription use only.

L.A. Ariend

(Division Sign-Off) Division of Anesthesiology, General Hospital Infection Control, Dental Devices

K082657 510(k) Number:

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

.

Concurrence of CDRH, Office of Device Evaluation (ODE)